Contraception in Cardiac Disease
A 29-year-old woman with a mechanical mitral valve replacement is on lifelong warfarin with an INR of 2.8. She attends the family planning clinic for contraceptive advice. She has no children yet, wants a reversible method, and has regular cycles with moderate menstrual flow. She is a nonsmoker. Which of the following is the most appropriate contraceptive method?
- A.Progestogen-only oral contraceptive pillsCorrect
- B.Combined estrogen and progestogen pills
- C.Copper intrauterine contraceptive device
- D.Laparoscopic bilateral tubal ligation
Explanation
A woman with a mechanical valve on anticoagulation has two competing hazards to respect when choosing contraception: thromboembolic risk and bleeding risk. Estrogen increases hepatic synthesis of clotting factors and reduces protein S, raising venous and arterial thrombotic risk, so combined hormonal contraception is a WHO Medical Eligibility Criteria category 4 method in complicated valvular heart disease. Progestogen-only methods do not carry this thrombotic penalty, are reversible, require no anesthesia, and often reduce menstrual blood loss, which is an added advantage in an anticoagulated woman. A copper device is estrogen-free and effective, but it typically increases menstrual blood loss by 30 to 50 percent, which is poorly tolerated on warfarin, and insertion in a woman with a prosthetic valve carries a small vasovagal and bleeding concern. Sterilization is irreversible and requires general anesthesia and pneumoperitoneum, both hazardous in significant cardiac disease, and it is inappropriate for a nulliparous 29-year-old who wants future fertility. A levonorgestrel-releasing intrauterine system is an excellent alternative because it reduces bleeding, but progestogen-only pills are the safest first offer that also satisfies her wish for a simple reversible method. The general rule is that in cardiac disease you avoid estrogen and avoid unnecessary surgery.
Why each option
- A.
- Correct. Progestogen-only methods do not raise thromboembolic risk, are fully reversible, avoid anesthesia, and tend to lighten menstrual bleeding.
- B.
- Estrogen-containing pills increase thrombotic risk and are absolutely contraindicated in complicated valvular heart disease and in women anticoagulated for a prosthetic valve.
- C.
- Copper devices increase menstrual blood loss, which is a significant problem in a woman anticoagulated to an INR of 2.8.
- D.
- Tubal ligation is irreversible and requires general anesthesia and pneumoperitoneum, which are poorly tolerated in significant cardiac disease, and she has not completed her family.
Reference: WHO Medical Eligibility Criteria for Contraceptive Use, 5th ed., 2015; UpToDate 2025, Contraception in women with cardiovascular disease
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank